Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

This study has been terminated.
(Lack of drug efficacy)
Sponsor:
Collaborator:
Jubilant Innovation Ltd.
Information provided by (Responsible Party):
University of Utah
ClinicalTrials.gov Identifier:
NCT01149434
First received: June 22, 2010
Last updated: July 23, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)